Apricus Biosciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mokelumne river who wrote (1805)	3/30/2016 3:23:02 PM
From: Strong Long	of 2026

James great points here and on the other board. While there are those on the other board that may criticize longs that were here for Vitaros, it is very important to remember that the US was in play long before they showed up with their criticism. Now that it's back in play (and I wonder who's baby that was to reacquire rights) US approval is paramount to moving APRI in a positive direction in the next year. It would be particularly nice if Pfizer sees it as an opportunity to expand in the ED market. I've been concerned that the batch out of specifications issue(s) in Europe might be a deterrent towards US approval without further trials. Perhaps that's over reacting? It sure would be nice to see a product with the skin permeation enhancer win approval here in the US. Who knows what possibilities that might end up opening... James, Eman, PR thanks for your responses

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next